Immucell (ICCC) Net Margin (2010 - 2026)
Immucell's (ICCC) quarterly Net Margin came in at 37.36% in Q4 2025, down 4400.0% YoY from 0.87% in Q4 2024, and down 1372.03% on a QoQ basis from 2.54% in Q3 2025.
Immucell (ICCC) Net Margin (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Net Margin data on file, last reported at 37.36% in Q4 2025.
- Quarterly Net Margin fell 4400.0% year-over-year to 37.36% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 3.76% (up 647.0% YoY) and the FY2025 annual result came in at 3.76%, up 438.0% from the prior year.
- Net Margin fell to 37.36% in Q4 2025, from 2.54% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 17.94% in Q1 2025 to a low of 2543.0% in Q2 2024.
- A 5-year average of 144.93% and a median of 10.74% in 2021 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2024 — Net Margin tumbled 250395 bps — and 2025, when it jumped 255079 bps.
- Tracing ICCC's Net Margin over 5 years: stood at 1.36% in 2021, then sank by 3128 bps to 41.23% in 2022, then jumped by 58 bps to 17.42% in 2023, then soared by 138 bps to 6.64% in 2024, then sank by 663 bps to 37.36% in 2025.
- The last three Net Margin figures came in at 37.36% (Q4 2025), 2.54% (Q3 2025), and 7.79% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 12.74% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -3.12% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -16.51% |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn | 25.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.53% |
| Dec 31, 2025 | -37.36% |
| Sep 30, 2025 | -2.54% |
| Jun 30, 2025 | 7.79% |
| Mar 31, 2025 | 17.94% |
| Dec 31, 2024 | 6.64% |
| Sep 30, 2024 | -11.67% |
| Jun 30, 2024 | -2,543.00% |
| Mar 31, 2024 | -6.03% |
| Sep 30, 2023 | -17.42% |
| Jun 30, 2023 | -39.06% |
| Mar 31, 2023 | -67.17% |
| Dec 31, 2022 | -41.23% |
| Sep 30, 2022 | -13.66% |
| Jun 30, 2022 | -11.96% |
| Mar 31, 2022 | 8.56% |
| Dec 31, 2021 | 1.36% |
| Sep 30, 2021 | 2.87% |
| Jun 30, 2021 | 3.11% |
| Mar 31, 2021 | -10.74% |